This funding record is inactive. Please see the program website or contact the program sponsor to determine if this program is currently accepting applications or will open again in the future.

Improving Access to Overdose Treatment (OD Treatment Access)


Additional Links

Notice of Funding Opportunity (


Application Deadline: Mar 24, 2023


Substance Abuse and Mental Health Services Administration (SAMHSA)


Awards funding to Federally Qualified Health Centers (FQHC), opioid treatment programs, or practitioners to expand access to naloxone and other medications approved by the Food and Drug Administration (FDA) for emergency treatment of known or suspected opioid overdose. Supports the development of and collaboration on best practices for prescribing and co-prescribing overdose reversal drugs at the community level by partnering with other prescribers. Targets specific urban or rural populations, especially those disproportionately impacted by overdose, to address their unique challenges, provide culturally informed training programs, and prepare key workforce to prevent and reduce overdose and overdose deaths.

Required activities include:

  • Implement scalable training of trainers (ToT) programs using an established ToT model, either in-person, virtually, or hybrid, to providers and pharmacists who will provide training locally
  • Register trainees and secure their commitment to offer the training in their local regions
  • Offer a curriculum and resources to healthcare providers and pharmacists that includes best practice protocols for prescribing a drug or device approved by the Federal Food, Drug, and Cosmetic Act for emergency treatment of known or suspected opioid overdose
  • Develop and implement protocols to connect patients who have experienced a drug overdose to appropriate treatment, including medications for opioid use disorder (MOUD) and other appropriate behavioral health services, such as counseling, peer support services, psychosocial services, and person-centered care
  • Create a plan to sustain the program after the grant period has ended
  • Provide specific information on the ToT framework, such as training topics and models, implementation plans, learning theories, proficiency measures, and identifying training recipients

No more that 20% of a grant award may be used to purchase drugs or devices approved or cleared under the Federal Food, Drug, and Cosmetic Act for emergency treatment of known or suspected opioid overdose.

Amount of Funding

Award ceiling: $200,000 per year
Project period: Up to 5 years
Estimated number of awards: 7
Estimated total program funding: $1,400,000

Who Can Apply

Applications may be submitted by:

  • Federally Qualified Health Centers (FQHCs) as defined in section 1861(aa) of the Social Security Act
  • Opioid treatment programs as defined under part 8 of title 42, Code of Federal Regulations
  • Practitioners dispensing narcotic drugs pursuant to section 303(g) of the Controlled Substances Act

Applicants proposing to serve rural communities must demonstrate that the project will be implemented in a community not located in a metropolitan statistical area (MSA), as defined by the U.S. Office of Management and Budget, and has been disproportionately impacted by overdose.

Geographic Coverage


What This Program Funds

Capacity Building • New Program • Operating Costs and Staffing • Training Providers

Application Process

Application instructions, requirements, and other information about the online application process can be found in the funding announcement.


For programmatic or technical questions:
Kristen K. Harper, M.Ed.

For grants management or budget questions:

For grant review process and application status questions:
Emily Chan

Topics This Program Addresses

Emergency Planning • Harm Reduction • Healthcare Workforce • Medication-Assisted Treatment (MAT) • Mental Health • Naloxone • Opioids • Overdose Prevention • Substance Use Disorder • Treatment